YOKU [YOUKU TUDOU] 6-K: (Original Filing)

[Youku Tudou Announces Fourth Quarter and Fiscal Year 2013 Unaudited Financial Results Achieved Quarterly Non-GAAP Profitability; Mobile Monetization Reached 10% BEIJING , China, February 28, 201 4 — Youku Tudou Inc. (NYSE: YOKU, and formerly Youku Inc. or “Youku” ), China’s leading Internet television company (“Youku Tudou” or the “Company”) , today announced its unaudited financial results for fourth quarter] [YOUKU TUDOU INC. 11/F, SinoSteel Plaza , 8 Haidian Street Beijing 100080 , People’s Republic of China Form 20-F x Form 40-F o o o Yes o No x YOUKU TUDOU INC.]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

YOKU [YOUKU TUDOU] 6-K: Youku Tudou Announces Fourth Quarter and Fiscal Year

[Youku Tudou Announces Fourth Quarter and Fiscal Year 2013 Unaudited Financial Results Achieved Quarterly Non-GAAP Profitability; Mobile Monetization Reached 10% BEIJING , China, February 28, 201 4 — Youku Tudou Inc. (NYSE: YOKU, and formerly Youku Inc. or “Youku” ), China’s leading Internet television company (“Youku Tudou” or the “Company”) , today announced its unaudited financial results for fourth quarter] [YOUKU TUDOU INC. 11/F, SinoSteel Plaza , 8 Haidian Street Beijing 100080 , People’s Republic of China Form 20-F x Form 40-F o o o Yes o No x YOUKU TUDOU INC.]

MR [Mindray Medical International] 6-K: Mindray Announces 2013 Fourth Quarter and Full Year

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

LAS [Lentuo International] CORRESP: (Original Filing)

[March 3 , 201 4 Jennifer Thompson, Accounting Branch Chief Sondra Snyder, Staff Accountant Andrew Blume, Staff Accountant Division of Corporate Finance 100 F Street, NE Re: Lentuo International Inc. Form 20-F for Fiscal Year Ended December 31, 2012 File No. 001-34987 Dear Ms. Thompson, Ms. Snyder and Mr. Blume: I refer to your letter to Mr. Hetong Guo, dated]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

LAS [Lentuo International] CORRESP: March 3 , 201 4 Jennifer Thompson, Accounting

[March 3 , 201 4 Jennifer Thompson, Accounting Branch Chief Sondra Snyder, Staff Accountant Andrew Blume, Staff Accountant Division of Corporate Finance 100 F Street, NE Re: Lentuo International Inc. Form 20-F for Fiscal Year Ended December 31, 2012 File No. 001-34987 Dear Ms. Thompson, Ms. Snyder and Mr. Blume: I refer to your letter to Mr. Hetong Guo, dated]

MR [Mindray Medical International] 6-K: Mindray Increases its Existing Share Repurchase Program by

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

QUNR [Qunar Cayman Islands] 6-K: (Original Filing)

[Qunar Reports Fourth Quarter and Fiscal Year 2013 Financial Results Revenue Growth Accelerates in the Fourth Quarter Company Announces US$300 Million Revolving Credit Facility from Baidu BEIJING, Feb. 27, 2014 (GLOBE NEWSWIRE) — Qunar Cayman Islands Limited (Nasdaq: QUNR) (“Qunar” or the “Company”), China’s leading search-based travel commerce platform, today announced its unaudited financial results for the fourth quarter and] [FORM 6-K QUNAR CAYMAN ISLANDS LIMITED 17th Floor, Viva Plaza, Building 18, Yard 29, Suzhou Street, Haidian District Beijing 100080 The People’s Republic of China Form 20-F x Form 40-F o o o QUNAR CAYMAN ISLANDS LIMITED]

SFUN [SouFun] SC 13G: (Original Filing)

[Lone Pine Capital LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 3,671,114 Ordinary Shares based on direct ownership of 3,671,114 ADS. 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER]

Skip to toolbar